• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接种疫苗的长期护理机构居民中,由 SARS-CoV-2 变体引起的免疫功能受损和高攻击率。

Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residents.

机构信息

Department of Health Security, Infectious Disease Control and Vaccinations Unit, Finnish Institute for Health and Welfare, Helsinki, Finland.

European Program for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control, (ECDC), Stockholm, Sweden.

出版信息

Immun Inflamm Dis. 2022 Sep;10(9):e679. doi: 10.1002/iid3.679.

DOI:10.1002/iid3.679
PMID:36039644
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9382858/
Abstract

INTRODUCTION

Long-term care facilities (LTCF) residents are at high risk for severe coronavirus disease 2019 (COVID-19), and therefore, COVID-19 vaccinations were prioritized for residents and personnel in Finland at the beginning of 2021.

METHODS

We investigated COVID-19 outbreaks in two LTCFs, where residents were once or twice vaccinated. After the outbreaks we measured immunoglobulin G (IgG) antibodies to severe acute respiratory syndrome coronavirus 2 spike glycoprotein, neutralizing antibody (NAb) titers, and cell-mediated immunity markers from residents and healthcare workers (HCWs).

RESULTS

In LTFC-1, the outbreak was caused by an Alpha variant (B.1.1.7) and the attack rate (AR) among once vaccinated residents was 23%. In LTCF-2 the outbreak was caused by a Beta variant (B.1.351). Its AR was 47% although all residents had received their second dose 1 month before the outbreak. We observed that vaccination had induced lower IgG concentrations, NAb titers and cell-mediated immune responses in residents compared to HCWs. Only 1/8 residents had NAb to the Beta variant after two vaccine doses.

CONCLUSIONS

The vaccinated elderly remain susceptible to breakthrough infections caused by Alpha and Beta variants. The weaker vaccine response in the elderly needs to be addressed in vaccination protocols, while new variants capable of evading vaccine-induced immunity continue to emerge.

摘要

简介

长期护理机构(LTCF)的居民感染 2019 年冠状病毒病(COVID-19)的风险很高,因此,2021 年初芬兰优先为居民和工作人员接种 COVID-19 疫苗。

方法

我们调查了两家 LTCF 中发生的 COVID-19 疫情,这些机构的居民接受过一次或两次疫苗接种。在疫情爆发后,我们测量了居民和医护人员(HCW)的严重急性呼吸综合征冠状病毒 2 刺突糖蛋白的免疫球蛋白 G(IgG)抗体、中和抗体(NAb)滴度和细胞介导免疫标志物。

结果

在 LTFC-1,疫情由 Alpha 变体(B.1.1.7)引起,一次接种疫苗的居民的发病率(AR)为 23%。在 LTCF-2,疫情由 Beta 变体(B.1.351)引起。尽管所有居民在疫情爆发前一个月都接种了第二剂疫苗,但 AR 仍为 47%。我们观察到,与 HCW 相比,疫苗接种在居民中诱导的 IgG 浓度、NAb 滴度和细胞介导的免疫反应较低。在接受两剂疫苗接种后,仅有 1/8 的居民对 Beta 变体具有 NAb。

结论

接种疫苗的老年人仍易感染 Alpha 和 Beta 变体引起的突破性感染。需要在疫苗接种方案中解决老年人较弱的疫苗反应问题,而新的能够逃避疫苗诱导免疫的变体继续出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/1328cfa43ef7/IID3-10-e679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/a970ea8fff6b/IID3-10-e679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/1984d1ccedb2/IID3-10-e679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/1328cfa43ef7/IID3-10-e679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/a970ea8fff6b/IID3-10-e679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/1984d1ccedb2/IID3-10-e679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fce0/9382858/1328cfa43ef7/IID3-10-e679-g001.jpg

相似文献

1
Impaired immunity and high attack rates caused by SARS-CoV-2 variants among vaccinated long-term care facility residents.接种疫苗的长期护理机构居民中,由 SARS-CoV-2 变体引起的免疫功能受损和高攻击率。
Immun Inflamm Dis. 2022 Sep;10(9):e679. doi: 10.1002/iid3.679.
2
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects.医护人员和老年受试者接种第三剂 mRNA 疫苗后对 SARS-CoV-2 奥密克戎变异株的中和抗体。
Eur J Immunol. 2022 May;52(5):816-824. doi: 10.1002/eji.202149785. Epub 2022 Mar 25.
3
Impact of Prior Infection on SARS-CoV-2 Antibody Responses in Vaccinated Long-Term Care Facility Staff.既往感染对长期护理机构接种疫苗工作人员中 SARS-CoV-2 抗体反应的影响。
mSphere. 2022 Aug 31;7(4):e0016922. doi: 10.1128/msphere.00169-22. Epub 2022 Jul 5.
4
Durable Antibody Responses in Staff at Two Long-Term Care Facilities, during and Post SARS-CoV-2 Outbreaks.在 SARS-CoV-2 爆发期间和之后,两家长期护理机构工作人员的持久抗体反应。
Microbiol Spectr. 2021 Sep 3;9(1):e0022421. doi: 10.1128/Spectrum.00224-21. Epub 2021 Jul 21.
5
Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.BNT162b2 或 ChAdOx1 nCoV-19 疫苗单剂接种后在居住护理院居民和工作人员中的体液和细胞免疫应答特征(VIVALDI):一项观察性研究。
Lancet Healthy Longev. 2021 Sep;2(9):e544-e553. doi: 10.1016/S2666-7568(21)00168-9. Epub 2021 Aug 19.
6
Effectiveness of mRNA BNT162b2 COVID-19 vaccine against SARS-CoV-2 Delta variant among elderly residents from a long-term care facility, South of France, May 2021.mRNA BNT162b2 新冠疫苗在法国南部长期护理机构老年居民中预防 SARS-CoV-2 德尔塔变异株的有效性,2021 年 5 月。
Eur Rev Med Pharmacol Sci. 2022 Apr;26(7):2586-2591. doi: 10.26355/eurrev_202204_28496.
7
Effectiveness of BNT162b2 mRNA Coronavirus Disease 2019 (COVID-19) Vaccine Against Acquisition of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Among Healthcare Workers in Long-Term Care Facilities: A Prospective Cohort Study.BNT162b2 mRNA 冠状病毒病 2019(COVID-19)疫苗在长期护理机构医护人员中预防严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)获得性感染的有效性:一项前瞻性队列研究。
Clin Infect Dis. 2022 Aug 24;75(1):e755-e763. doi: 10.1093/cid/ciab918.
8
Heterologous and homologous COVID-19 mRNA vaccination schemes for induction of basic immunity show similar immunogenicity regarding long-term spike-specific cellular immunity in healthcare workers.不同和同源的 COVID-19 mRNA 疫苗接种方案在诱导医护人员的长期刺突特异性细胞免疫方面显示出相似的免疫原性。
Vaccine. 2024 Aug 30;42(21):126132. doi: 10.1016/j.vaccine.2024.07.033. Epub 2024 Jul 20.
9
Sequencing analysis of SARS-CoV-2 cases in Slovenian long-term care facilities to support outbreak control.对斯洛文尼亚长期护理机构中 SARS-CoV-2 病例进行测序分析,以支持疫情控制。
Front Public Health. 2024 May 15;12:1406777. doi: 10.3389/fpubh.2024.1406777. eCollection 2024.
10
Healthcare Workers in South Korea Maintain a SARS-CoV-2 Antibody Response Six Months After Receiving a Second Dose of the BNT162b2 mRNA Vaccine.韩国医护人员接种第二剂 BNT162b2 mRNA 疫苗 6 个月后仍保持对 SARS-CoV-2 的抗体应答。
Front Immunol. 2022 Jan 31;13:827306. doi: 10.3389/fimmu.2022.827306. eCollection 2022.

引用本文的文献

1
Why are some outbreaks worse than others? COVID-19 outbreak management strategies from a PHU perspective.为什么有些疫情比其他疫情更严重?从公共卫生单位角度看 COVID-19 疫情管理策略。
BMC Public Health. 2023 Mar 30;23(1):597. doi: 10.1186/s12889-023-15498-x.
2
Qualitative Insights into Vaccine Uptake of Nursing Staff in Long-Term Care Facilities in Finland.芬兰长期护理机构护理人员疫苗接种情况的质性洞察
Vaccines (Basel). 2023 Feb 23;11(3):530. doi: 10.3390/vaccines11030530.

本文引用的文献

1
Neutralizing antibodies to SARS-CoV-2 Omicron variant after third mRNA vaccination in health care workers and elderly subjects.医护人员和老年受试者接种第三剂 mRNA 疫苗后对 SARS-CoV-2 奥密克戎变异株的中和抗体。
Eur J Immunol. 2022 May;52(5):816-824. doi: 10.1002/eji.202149785. Epub 2022 Mar 25.
2
Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination.mRNA 疫苗接种后中度至重症突破性 COVID-19 感染的免疫反应。
Front Immunol. 2022 Jan 25;13:816220. doi: 10.3389/fimmu.2022.816220. eCollection 2022.
3
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization.
奥密克戎对抗体中和作用的逃逸显著。
Nature. 2022 Feb;602(7898):671-675. doi: 10.1038/s41586-021-04389-z. Epub 2021 Dec 23.
4
Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant by Sera From BNT162b2 or CoronaVac Vaccine Recipients.BNT162b2 或科兴疫苗接种者血清对严重急性呼吸综合征冠状病毒 2 奥密克戎变异株的中和作用。
Clin Infect Dis. 2022 Aug 24;75(1):e822-e826. doi: 10.1093/cid/ciab1041.
5
Antibody Response and Variant Cross-Neutralization After SARS-CoV-2 Breakthrough Infection.SARS-CoV-2突破性感染后的抗体反应及变异株交叉中和作用
JAMA. 2022 Jan 11;327(2):179-181. doi: 10.1001/jama.2021.22898.
6
Effectiveness of BNT162b2 mRNA COVID-19 vaccine against SARS-CoV-2 variant Beta (B.1.351) among persons identified through contact tracing in Israel: A prospective cohort study.以色列通过接触者追踪识别出的人群中BNT162b2 mRNA新冠疫苗对严重急性呼吸综合征冠状病毒2变异株贝塔(B.1.351)的有效性:一项前瞻性队列研究。
EClinicalMedicine. 2021 Dec;42:101190. doi: 10.1016/j.eclinm.2021.101190. Epub 2021 Nov 29.
7
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis.中和抗体滴度作为预测对 SARS-CoV-2 变异体的保护作用以及加强免疫的影响的指标:一项荟萃分析。
Lancet Microbe. 2022 Jan;3(1):e52-e61. doi: 10.1016/S2666-5247(21)00267-6. Epub 2021 Nov 15.
8
Effectiveness of vaccination against SARS-CoV-2 infection and Covid-19 hospitalisation among Finnish elderly and chronically ill-An interim analysis of a nationwide cohort study.接种 SARS-CoV-2 疫苗对芬兰老年人群和慢性病患者感染新冠病毒和住院的效果:一项全国性队列研究的中期分析。
PLoS One. 2021 Nov 18;16(11):e0258704. doi: 10.1371/journal.pone.0258704. eCollection 2021.
9
A Highly Sensitive and Specific SARS-CoV-2 Spike- and Nucleoprotein-Based Fluorescent Multiplex Immunoassay (FMIA) to Measure IgG, IgA, and IgM Class Antibodies.一种高灵敏度和特异性的基于 SARS-CoV-2 刺突蛋白和核蛋白的荧光多重免疫分析(FMIA),用于测量 IgG、IgA 和 IgM 类抗体。
Microbiol Spectr. 2021 Dec 22;9(3):e0113121. doi: 10.1128/Spectrum.01131-21. Epub 2021 Nov 17.
10
Persistence of neutralizing antibodies a year after SARS-CoV-2 infection in humans.SARS-CoV-2 感染人类一年后中和抗体的持久性。
Eur J Immunol. 2021 Dec;51(12):3202-3213. doi: 10.1002/eji.202149535. Epub 2021 Oct 8.